These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14096867)

  • 1. [EFFECT OF A NEW DIURETIC, CYCLOPENTHIAZIDE, ON THE URINARY ELIMINATION OF ELECTROLYTES, ON RENAL FUNCTION AND ON ARTERIAL PRESSURE IN NORMAL AND HYPERTENSIVE SUBJECTS].
    BALESTRI PL; ZAMPIERI A
    Minerva Nefrol; 1963; 10():234-9. PubMed ID: 14096867
    [No Abstract]   [Full Text] [Related]  

  • 2. CYCLOPENTHIAZIDE WITH AND WITHOUT SUPPLEMENTARY POTASSIUM. EFFECTS IN LONG-TERM TREATMENT OF PATIENTS WITH NEGLIGIBLE EXCRETORY ELIMINATION OF OEDEMA.
    DYBKAER R; FRANTZEN A
    Acta Med Scand; 1964 Feb; 175():135-43. PubMed ID: 14124627
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of cyclopenthiazide and a combination of cyclopenthiazide and progesterone on diuresis, aldosterone and electrolytes of edematous patients].
    PILIEGO N; PINTO L; ROSSINI P
    Rass Fisiopatol Clin Ter; 1962; 34():495-502. PubMed ID: 13943588
    [No Abstract]   [Full Text] [Related]  

  • 4. SOME ASPECTS OF DIURETIC ACTIVITY OF CYCLOPENTHIAZIDE AND EFFECT OF SPIRONOLACRONE ON THEM, COMPARED WITH MERSALYL.
    MEHTA DJ; SUCHAK NG; MANDREKAR SS; KHOKHANI RC; SHAH MJ; SHETH UK
    Indian J Physiol Pharmacol; 1963 Apr; 7():106-15. PubMed ID: 14064077
    [No Abstract]   [Full Text] [Related]  

  • 5. [SOME PHYSICO-PHARMACOLOGICAL ASPECTS OF RENAL EXCRETION].
    LEITAO JA
    Med Contemp; 1964 Jul; 82():243-69. PubMed ID: 14205691
    [No Abstract]   [Full Text] [Related]  

  • 6. POLYTHIAZIDE IN THE MANAGEMENT OF HYPERTENSIVE DISEASE. I. EFFECTS OF WATER AND ELECTROLYTE METABOLISM.
    TALSO PJ; YOUNG L; TANSEY WJ
    Curr Ther Res Clin Exp; 1964 Mar; 6():162-8. PubMed ID: 14131416
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
    Bolli P; Simpson FO; Waal-Manning HJ
    Lancet; 1978 Sep; 2(8090):595-8. PubMed ID: 80525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A NEW PARENTERAL DIURETIC, POLYTHIAZIDE, IN THE TREATMENT OF EDEMA.
    OZEN MA; KADIOGLU A
    Curr Ther Res Clin Exp; 1964 Aug; 6():505-15. PubMed ID: 14202210
    [No Abstract]   [Full Text] [Related]  

  • 9. [2 NEW DIURETIC DRUGS: QUINETHAZONE AND ETHACRYNIC ACID].
    RIVERA A; ABRAHAM J; CHAVEZ JM; ROESCH F
    Rev Invest Clin; 1964; 16():237-70. PubMed ID: 14206650
    [No Abstract]   [Full Text] [Related]  

  • 10. PHARMACODYNAMIC EFFECTS OF A NEW DIURETIC DRUG, ETHACRYNIC ACID.
    BREST AN; ONESTI G; SELLER R; RAMIREZ O; HEIDER C; MOYER JH
    Am J Cardiol; 1965 Jul; 16():99-105. PubMed ID: 14314210
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECT OF HYDROCHLOROTHIAZIDE ON SERUM AND URINARY CALCIUM AND URINARY CITRATE.
    SEITZ H; JAWORSKI ZF
    Can Med Assoc J; 1964 Feb; 90(6):414-20. PubMed ID: 14123666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RENAL HEMODYNAMIC AND ELECTROLYTE EXCRETION EFFECTS OF THE URINARY DIURETIC FACTOR (UDF).
    LITTLE JM
    J Pharmacol Exp Ther; 1965 Jun; 148():363-6. PubMed ID: 14334271
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF EQUI-PRESSOR DOSES OF SYNTHETIC ALPHA- AND BETA-ANGIOTENSIN II ON URINARY VOLUME AND URINARY ELECTROLYTES IN NORMOTENSIVE SUBJECTS.
    EISALO A; RAESAENEN V
    Acta Med Scand; 1965 Jan; 177():121-6. PubMed ID: 14251844
    [No Abstract]   [Full Text] [Related]  

  • 14. THE EFFECT OF ANGIOTENSIN ON THE FUNCTION OF THE SEPARATE KIDNEYS IN PATIENTS WITH UNILATERAL RENAL ARTERY STENOSIS.
    BROWN JJ; MATTHEW GK; ROBERTSON JI
    Clin Sci; 1964 Jun; 26():381-95. PubMed ID: 14191267
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of equivalent antihypertensive doses of mefruside and cyclopenthiazide on serum electrolytes, uric acid and glucose tolerance in hypertensive patients.
    Waal-Manning HJ
    Clin Exp Pharmacol Physiol; 1975; 2(2):141-6. PubMed ID: 1095262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TREATMENT OF EDEMATOUS SYNDROMES; COMBINATION OF CYCLOPENTHIAZIDE WITH PREDNISONE].
    JACONO A; VITALE P; DEDIVITIIS O; SCALFI L
    Policlinico Med; 1964 Feb; 71():1-13. PubMed ID: 14143287
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON CYCLOPENTHIAZIDE (AWD-DRESDEN) THERAPY].
    KAEDING A; KLINKMANN H
    Z Gesamte Inn Med; 1964 Oct; 19():755-9. PubMed ID: 14231674
    [No Abstract]   [Full Text] [Related]  

  • 18. [COMPARATIVE STUDY OF THE HYPOSODIC REGIME AND CYCLOPENTHIAZIDE IN THE TREATMENT OF THE EDEMA SYNDROME].
    DONOSO P; CUELLAR VE; RAMIREZ N; MANCILLA J; BEHM H
    Rev Med Chil; 1963 Nov; 91():845-8. PubMed ID: 14125676
    [No Abstract]   [Full Text] [Related]  

  • 19. THE ANTIDIURETIC PROPERTIES OF CHLOROTHIAZIDE IN DIABETES INSIPIDUS DOGS. I. EFFECT ON SOLUTE, WATER, AND ELECTROLYTE EXCRETION. REP 582.
    GILLENWATER JY
    Rep US Army Med Res Lab; 1963 Jul; ():1-27. PubMed ID: 14131251
    [No Abstract]   [Full Text] [Related]  

  • 20. CARDIAC AND RENAL HYPERRESPONSIVENESS TO ACUTE PLASMA VOLUME EXPANSION IN HYPERTENSION.
    ULRYCH M; HOFMAN J; HEJL Z
    Am Heart J; 1964 Aug; 68():193-203. PubMed ID: 14204314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.